Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early high-dose somatostatin for prevention of pancreatic pseudocyst in severe acute pancreatitis
ChiCTR-TRC-09000579Phase 4Completed
- Sponsor
- Changhai Hospital
- Start
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of somatostatin in acute pancreatitis (AP) (2 arms), sponsored by Changhai Hospital. Primary endpoint: Incidence of pancreatic pseudocyst. Started Dec 2009; status: completed.
02
Drugs
somatostatin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR-TRC-09000579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000579.